A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

By Rioja I.   Terencio M.C.   Ubeda A.   Molina P.   Tarraga A.   Gonzalez-Tejero A.   Alcaraz M.J.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

Novel Colchicine Derivatives and their Anti-cancer Activity

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2538-2558

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite

Novel Dual Inhibitors of Nuclear Factor-Kappa B (NF-κ B) and Cyclooxygenase- 2 (COX-2): Synthesis, In Vitro Anticancer Activity and Stability Studies of Lantadene–Non Steroidal Anti-inflammatory Drug (NSAID) Conjugates

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 8, 2014-04 ,pp. : 991-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Design of Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic, Anti-Inflammatory Drugs with Potential Utility as Anti-Cancer Agents

By  

Current Drug Targets, Vol. 2, Iss. 1, 2001-03 ,pp. : 79-106

Bentham Science Publishers

Access to resources Recommend Favorite